Gary Wilcox

This profile gathers the share dealings of Gary Wilcox across 2 companies, led by Icos Corp and Cocrystal Pharma, Inc. Over a trading history stretching from 5 January 2006 to 1 September 2016, the count stands at 19 filings.

Purchases make up the whole of the open-market record (3 purchases, €72k). Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Besides market trades, the filings include 4 share grants and 4 option exercises. In 2016 alone, the filings show 2 purchases and no sales.

In size, the median ticket on the buying side is €23k. Looking at 3 purchases old enough to measure, the stock rose over the following 90 days in 0% of cases; the median change was -8.7%. This is a record of the past, not a forecast.

Most recently, on 6 September 2016, the filings show an open-market purchase worth €3,660 in Cocrystal Pharma, Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. US insiders must file a Form 4 within two business days of a trade. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.